Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid versus placebo for acute non-traumatic intracerebral hemorrhage
IRCT20220520054927N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of tranexamic acid in intracerebral hemorrhage (ICH) (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: In-hospital mortality, Hematoma expansion on follow-up brain CT scan and 2 more. Started Jul 2022; status: completed.
02
Drugs
tranexamic acid
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on IRCT20220520054927N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220520054927N1.